The 3rd Joint Session between TDDW - JDDW – KDDW

September 28, 2019(Saturday)08:00-11:00
Kaohsiung Exhibition Center (Conference Room D, 301b)

Long-term effects of Helicobacter pylori eradication in the Asia-Pacific region: Other benefits or concerns?

* you can left or right swipe programme.
Time Topic Speaker
Yi-Chia Lee (Taiwan)
Kazunari Murakami (Japan)
Jae J. Kim (Korea)
Jyh-Ming Liou (Taiwan)
Takashi Kawai (Japan)
Yong Chan Lee (Korea)
Long-term effect of Helicobacter pylori eradication, benefits beyond gastric cancer prevention Chieh-Chang Chen
(Taiwan)
Gastric cancer after H. pylori eradication therapy in Japan Masanori Ito
(Japan)
The effect of Helicobacter pylori eradication on the tumor microenvironment Nayoung Kim
(Korea)
Rising star
A two-stage screening program for gastric cancer prevention: a community-based study Tsung-Hsien Chiang
(Taiwan)
Long-term outcomes of endoscopic resection and metachronous cancer after endoscopic resection for adenocarcinoma of the esophagogastric junction in Japan Seiichiro Abe
(Japan)
Novel risk stratification for metachronous recurrence after curative endoscopic submucosal dissection for early gastric cancer Hyo-Joon Yang
(Korea)
* you can left or right swipe programme.
*Sessions:20 minute lecture/ per speaker (Oral 15 mins, Q&A 5 mins)
*Rising Star Program:10 minute lecture/ per speaker (Oral 7 mins, Q&A 3 mins)

Autoimmune pancreatitis: Current diagnosis & management in the Asia-Pacific Region

* you can left or right swipe programme.
Time Topic Speaker
Hsiu-Po Wang (Taiwan)
Kazuichi Okazaki (Japan)
Dong Ki Lee (Korea)
Wei-Chih Liao (Taiwan)
Kensuke Kubota (Japan)
Jong Kyun Lee (Korea)
Relationship between autoimmune pancreatitis and IgG4-sclerosing cholangitis Yu-Ting Kuo
(Taiwan)
Autoimmune pancreatitis in Japan Atsushi Masamune
(Japan)
Type 2 autoimmune pancreatitis in Asia Tae Jun Song
(Korea)
Rising star
Urinary trypsinogen-2 level predicts local complications of acute pancreatitis Hsing-Chien Wu
(Taiwan)
Identifying a new antigen of autoimmune pancreatitis Masahiro Shiokawa
(Japan)
Perspectives on clinical applications of CTCs in patients with pancreatic cancer Dong Uk Kim
(Korea)
* you can left or right swipe programme.
*Sessions:20 minute lecture/ per speaker (Oral 15 mins, Q&A 5 mins)
*Rising Star Program:10 minute lecture/ per speaker (Oral 7 mins, Q&A 3 mins)